A detailed history of Groupama Asset Managment transactions in Biogen Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 20,522 shares of BIIB stock, worth $3.24 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
20,522
Previous 12,710 61.46%
Holding current value
$3.24 Million
Previous $2.95 Billion 8.39%
% of portfolio
0.08%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$189.07 - $236.8 $1.48 Million - $1.85 Million
7,812 Added 61.46%
20,522 $3.19 Billion
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $148,796 - $184,878
-781 Reduced 5.79%
12,710 $2.95 Billion
Q1 2024

May 14, 2024

SELL
$212.02 - $267.71 $485,949 - $613,591
-2,292 Reduced 14.52%
13,491 $4.51 Billion
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $3.51 Million - $4.23 Million
15,783 New
15,783 $4.09 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.